Anti-fibrotic activity of natural products, herbal extracts and nutritional components for prevention of liver fibrosis: review

References

• Abdelwahed, A., et al., 2007. Study of antimutagenic and antioxidant activities of Gallic acid and 1,2,3,4,6-pentagalloylglucose from Pistacia lentiscus. Confirmation by microarray expression profiling. Chemico-biological interactions, 165(1), 1–13.
   PubMed Web of Science ®Google Scholar
• Ahmad, A., et al., 2015. Molecular targets of naturopathy in cancer research: bridge to modern medicine. Nutrients, 7(1), 321–334.
   PubMed Web of Science ®Google Scholar
• Al-Muzafar, H.M. and Amin, K.A., 2017. Probiotic mixture improves fatty liver disease by virtue of its action on lipid profiles, leptin, and inflammatory biomarkers. BMC complementary and alternative medicine, 17(1), 43.
   PubMedGoogle Scholar
• Attia, H., et al., 2016. The antifibrotic and fibrolytic properties of date fruit extract via modulation of genotoxicity, tissue-inhibitor of metalloproteinases and nuclear factor- kappa B pathway in a rat model of hepatotoxicity. BMC complementary and alternative medicine, 16(1), 414.
   PubMedGoogle Scholar
• Bataller, R. and Brenner, D.A., 2005. Liver fibrosis. Journal of Clinical Investigation, 115(2), 209–218.
   PubMed Web of Science ®Google Scholar
• Borthwick, L.A., et al., 2012. Transforming growth factor-beta1 (TGF-beta1) driven epithelial to mesenchymal transition (EMT) is accentuated by tumour necrosis factor alpha (TNFalpha) via crosstalk between the SMAD and NF-kappaB pathways. Cancer microenvironment, 5(1), 45–57.
   PubMedGoogle Scholar
• Brenner, D.A., 2009. Molecular pathogenesis of liver fibrosis. Transactions of the American clinical and climatological association, 120, 361–368.
   PubMedGoogle Scholar
• Cao, F., et al., 2018. Mogroside IVE attenuates experimental liver fibrosis in mice and inhibits HSC activation through downregulating TLR4-mediated pathways. International immunopharmacology, 55, 183–192.
   PubMed Web of Science ®Google Scholar
• Chamberlin, S.R., et al., 2014. Naturopathic practice at north American academic institutions: description of 300,483 visits and comparison to conventional primary care. Integrative medicine insights, 9, 7–15.
   PubMedGoogle Scholar
• Chen, J., et al., 2017. Gypenosides ameliorate CCl4-induced liver fibrosis by inhibiting the differentiation of hepatic progenitor cells into myofibroblasts. The American journal of Chinese medicine, 45(05), 1061–1074.
   PubMedGoogle Scholar
• Chen, Y.H., et al., 2015. Protective effects of Ocimum gratissimum polyphenol extract on CCl4-induced liver fibrosis in rats. Chinese journal of physiology, 58, 55–63.
   PubMed Web of Science ®Google Scholar
• Chiaramonte, M.G., et al., 2001. Studies of murine schistosomiasis reveal IL-13 blockade as a treatment for established and progressive liver fibrosis. Hepatology, 34(2), 273–282.
   PubMed Web of Science ®Google Scholar
• Clichici, S., et al., 2015. Silymarin inhibits the progression of fibrosis in the early stages of liver injury in CCl(4)-treated rats. Journal of medicinal food, 18(3), 290–298.
   PubMed Web of Science ®Google Scholar
• Coué, M., et al., 2019. Spirulina liquid extract protects against fibrosis related to non-alcoholic steatohepatitis and increases ursodeoxycholic acid. Nutrients, 11(1), 194.
   Web of Science ®Google Scholar
• De Bleser, P.J., et al., 1999. GSH levels discriminate between oxidative stress and transforming growth factorbeta signaling in activated rat hepatic stellate cells. Journal of biological chemistry, 274(48), 33881–33887.
   PubMed Web of Science ®Google Scholar
• Diesen, D.L. and Kuo, P.C., 2011. Nitric oxide and redox regulation in the liver: part II. Redox biology in pathologic hepatocytes and implications for intervention. The journal of surgical research, 167(1), 96–112.
   PubMed Web of Science ®Google Scholar
• Duval, F., et al., 2015. Liver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response. International journal of inflammation, 2015, 943497
   PubMedGoogle Scholar
• El-Lakkany, N.M., et al., 2012. Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis. Parasites & vectors, 5, 9–23.
   PubMed Web of Science ®Google Scholar
• El-Tantawy, W.H., Sabry, D., and Abd Al Haleem, E.N., 2017. Comparative study of the antifibrotic activity of some magnesium-containing supplements on experimental liver toxicity. Molecular study. Drug and chemical toxicology, 40(1), 47–56.
   PubMed Web of Science ®Google Scholar
• Farazi, P.A. and DePinho, R.A., 2006. Hepatocellular carcinoma pathogenesis: from genes to environment. Nature reviews cancer, 6(9), 674–687.
   PubMed Web of Science ®Google Scholar
• Faried, A., et al., 2007. Anticancer effects of gallic acid isolated from Indonesian herbal medicine, Phaleria macrocarpa (Scheff.) Boerl, on human cancer cell lines. International journal of oncology, 30(3), 605–613.
   PubMed Web of Science ®Google Scholar
• Friedman, S.L., 2003. Liver fibrosis—from bench to bedside. Journal of hepatology, 38(Suppl 1), 38–53.
   PubMed Web of Science ®Google Scholar
• Furtado, K.S., et al., 2012. Coffee and caffeine protect against liver injury induced by thioacetamide in male Wistar rats. Basic & clinical pharmacology & toxicology, 111(5), 339–347.
   PubMed Web of Science ®Google Scholar
• Giannitrapani, L., et al., 2014. Nanotechnology applications for the therapy of liver fibrosis. World journal of gastroenterology, 20(23), 7242–7251.
   PubMed Web of Science ®Google Scholar
• Guo, Y., et al., 2017. Hepatoprotective effects of Yulangsan flavone against carbon tetrachloride (CCl4)-induced hepatic fibrosis in rats . Phytomedicine: international journal of phytotherapy and phytopharmacology, 33, 28–35.
   PubMed Web of Science ®Google Scholar
• Horbelt, D., Denkis, A., and Knaus, P., 2012. A portrait of transforming growth factor beta superfamily signaling: background matters. The international journal of biochemistry & cell biology, 44(3), 469–474.
   PubMed Web of Science ®Google Scholar
• Huang, H.C., et al., 2011. New and bioactive lignans from the fruits of Schisandra sphenanthera. Food chemistry, 128(2), 348–357.
   PubMed Web of Science ®Google Scholar
• Hung, W.L., et al., 2014. Protective effects of garcinol on dimethylnitrosamine-induced liver fibrosis in rats. Food and function, 5(11), 2883–2891.
   PubMed Web of Science ®Google Scholar
• Ikaga, R., Li, D., and Yamazaki, T., 2017. Dietary β-conglycinin prevents acute ethanol-induced fatty liver in mice. Biochemical and biophysical research communications, 493(1), 542–547.
   PubMed Web of Science ®Google Scholar
• Jia, H., et al., 2014. Egg shell membrane ameliorates hepatic fibrogenesis in human C3A cells and rats through changes in PPARγ-Endothelin 1 signaling. Scientific reports, 4, 7473.
   PubMed Web of Science ®Google Scholar
• Kisseleva, T., et al., 2006. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. Journal of hepatology, 45(3), 429–438.
   PubMed Web of Science ®Google Scholar
• Koppula, S., et al., 2017. Anti-fibrotic effects of Orostachys japonicus A. Berger (Crassulaceae) on hepatic stellate cells and thioacetamide-induced fibrosis in rats. Nutrition research and practice, 11(6), 470–478.
   PubMed Web of Science ®Google Scholar
• Lee, U.E. and Friedman, S.L., 2011. Mechanisms of hepatic fibrogenesis. Best practice & research clinical gastroenterology, 25(2), 195–206.
   PubMed Web of Science ®Google Scholar
• Lee, Y.A., Wallace, M.C., and Friedman, S.L., 2015. Pathobiology of liver fibrosis: a translational success story. Gut, 64(5), 830–841.
   PubMed Web of Science ®Google Scholar
• Loguercio, C. and Festi, D., 2011. Silybin and the liver: from basic research to clinical practice. World journal of gastroenterology, 17(18), 2288–2301.
   PubMed Web of Science ®Google Scholar
• Masterton, G.S. and Hayes, P.C., 2010. Coffee and the liver: a potential treatment for liver disease? European journal of gastroenterology & hepatology, 22(11), 1277–1283.
   PubMed Web of Science ®Google Scholar
• Mata-Santos, H.A., et al., 2014. Silymarin reduces profibrogenic cytokines and reverses hepatic fibrosis in chronic murine schistosomiasis. Antimicrobial agents and chemotherapy, 58(4), 2076–2083.
   PubMed Web of Science ®Google Scholar
• Mazur, A., et al., 2007. Magnesium and the inflammatory response: potential physio- pathological implications. Archives of biochemistry and biophysics, 458(1), 48–56.
   PubMed Web of Science ®Google Scholar
• Milliman, W.B., Lamson, D.W., and Brignall, M.S., 2000. Hepatitis C; a retrospective study, literature review, and naturopathic protocol. Alternative medicine review, 5(4), 355–371.
   PubMedGoogle Scholar
• Morazzoni, P. and Bombardelli, E., 1995. Silybum marianum (Cardusarianum). Fitoterapia, 66, 3–42.
   Google Scholar
• Novo, E., et al., 2014. Cellular and molecular mechanisms in liver fibrogenesis. Archives of biochemistry and biophysics, 548, 20–37.
   PubMed Web of Science ®Google Scholar
• Onichtchouk, D., et al., 1999. Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature, 401(6752), 480–485.
   PubMed Web of Science ®Google Scholar
• Pellicoro, A., et al., 2014. Liver fibrosis andrepair: immune regulation of wound healing in a solid organ. Nature reviews immunology, 14(3), 181–194.
   PubMed Web of Science ®Google Scholar
• Pinzani, M., 2002. PDGF and signal transduction in hepatic stellate cells. Frontiers in bioscience, 7(4), d1720–726.
   PubMedGoogle Scholar
• Pinzani, M., et al., 1996. Expression of PDGF and its receptors in normal humanliver and during active hepatic fibrogenesis. The American journal of pathology, 148(3), 785–800.
   PubMed Web of Science ®Google Scholar
• Prystupa, A., et al., 2017. Association between serum selenium concentrations and levels of proinflammatory and profibrotic cytokines-IL-6 and GDF-15, in patients with alcoholic liver cirrhosis. International journal of environmental research public health, 14(4),
   PubMed Web of Science ®Google Scholar
• Rahman, M.M., Muse, A.Y., et al., 2017. Apocynin prevented inflammation and oxidative stress in carbon tetra chloride induced hepatic dysfunction in rats. Biomedicine & pharmacotherapy, 92, 421–428.
   PubMed Web of Science ®Google Scholar
• Ramaiah, S.K. and Jaeschke, H., 2007. Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicologic pathology, 35(6), 757–766.
   PubMed Web of Science ®Google Scholar
• Ramos‐Tovar, E., Flores‐Beltrán, R.E., and Galindo‐Gómez, S., 2018. Stevia rebaudiana tea prevents experimental cirrhosis via regulation of NF‐κB, Nrf2, transforming growth factor beta, Smad7, and hepatic stellate cell activation. Phytotherapy research, 32, 2568–2576.
   PubMed Web of Science ®Google Scholar
• Ramos-Tovar, E. and Muriel, P., 2017. Stevia as a putative hepatoprotector. In: P. Muriel, ed. Liver pathophysiol. Waltham, MA: Elsevier, 715–727.
   Google Scholar
• Rašković, A., et al., 2014. Antioxidant activity of rosemary (Rosmarinus officinalis L.) essential oil and its hepatoprotective potential. BMC complementary and alternative medicine, 14(1), 225.
   PubMedGoogle Scholar
• Ren, Z.P., et al., 2013. Effect of the protease inhibitor MG132 on the transforming growth factor-beta/Smad signaling pathway in HSC-T6 cells. Journal of huazhong university of science and technology [Medical Sciences], 33(4), 501–504.
   Google Scholar
• Rockey, D.C., 2008. Current and future anti-fibrotic therapies for chronic liver disease. Clinics in liver disease, 12(4), 939–962.
   PubMed Web of Science ®Google Scholar
• Seki, E., et al., 2007. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nature medicine, 13(11), 1324–1332.
   PubMed Web of Science ®Google Scholar
• Shi, A., et al., 2018. Activation of Nrf2 pathway and inhibition of NLRP3 inflammasome activation contribute to the protective effect of chlorogenic acid on acute liver injury. International immunopharmacology, 54, 125–130.
   PubMed Web of Science ®Google Scholar
• Smith, M.J. and Logan, A.C., 2002. Naturopathy. Medical clinics of north America, 86(1), 173–184.
   PubMed Web of Science ®Google Scholar
• Sokar, S.S., et al., 2017. Combination of sitagliptin and silymarin ameliorates liver fibrosis induced by CCl4 in rats. Biomedicine and pharmacotherapy, 89, 98–107.
   PubMed Web of Science ®Google Scholar
• Son, G., et al., 2007. Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis. American journal of physiology-gastrointestinal and liver physiology, 293(3), G631–G639.
   PubMed Web of Science ®Google Scholar
• Stauffer, J.K., et al., 2012. Chronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections. Hepatology, 56(4), 1567–1574.
   PubMed Web of Science ®Google Scholar
• Su, K.Y., et al., 2014. Taiwanese Green Propolis and Propolin G Protect the Liver from the Pathogenesis of Fibrosis via Eliminating TGF-β-Induced Smad2/3 Phosphorylation. Journal of agricultural and food chemistry, 62(14), 3192–3201.
   PubMed Web of Science ®Google Scholar
• Sunami, Y., et al., 2012. Hepatic activation of IKK/NF-kappaB signaling induces liver fibrosis via macrophage mediated chronic inflammation. Hepatology, 56(3), 1117–1128.
   PubMed Web of Science ®Google Scholar
• Trautwein, C., et al., 2015. Hepatic fibrosis: concept to treatment. Journal of hepatology, 62(1), S15–S24.
   PubMedGoogle Scholar
• Tzeng, J.I., et al., 2013. Silymarin decreases connective tissue growth factor to improve liver fibrosis in rats treated with CCl4. Phytotherapy research, 27(7), 1023–1028.
   PubMed Web of Science ®Google Scholar
• Urtasun, R., Conde de la Rosa, L., and Nieto, N., 2008. Oxidative and nitrosative stress and fibrogenic response. Clinics in liver disease, 12(4), 769–790, viii.
   PubMed Web of Science ®Google Scholar
• Wang, J., et al., 2014. Inhibitory effect of gallic acid on CCl4-mediated liver fibrosis in mice. Cell biochemistry and biophysics, 69(1), 21–26.
   PubMed Web of Science ®Google Scholar
• Wei, X.L., et al., 2015. Protective effects of extracts from pomegranate peels and seeds on liver fibrosis induced by CCl4 in rats. BMC complementary and alternative medicine, 15(1), 389.
   PubMedGoogle Scholar
• Wong, L., et al., 1994. Induction of beta-PDGF receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. Journal of clinical investigation, 94(4), 1563–1569.
   PubMed Web of Science ®Google Scholar
• Woodhoo, A., et al., 2012. Human antigen R contributes to hepatic stellate cell activation and liver fibrosis. Hepatology, 56(5), 1870–1882.
   PubMed Web of Science ®Google Scholar
• Wu, Q., et al., 2016. The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: an overview. Archives of toxicology, 90(8), 1817–1840.
   PubMed Web of Science ®Google Scholar
• Wu, S.J., et al., 2010. Curcumin and saikosaponin a inhibit chemical-induced liver inflammation and fibrosis in rats. The American journal of Chinese medicine, 38(01), 99–111.
   PubMedGoogle Scholar
• Wu, Y.L., et al., 2016. Cucurbitacin E ameliorates hepatic fibrosis in vivo and in vitro through activation of AMPK and blocking mTOR-dependent signaling pathway. Toxicology letters, 258, 147–158.
   PubMed Web of Science ®Google Scholar
• Yan, K., et al., 2012. p38 mitogen-activated protein kinase and liver X receptor-alpha mediate the leptin effect on sterol regulatory element binding protein-1c expression in hepatic stellate cells. Molecular medicine, 18(1), 10–18.
   PubMed Web of Science ®Google Scholar
• Yang, J., et al., 2011. NDRG2 ameliorates hepatic fibrosis by inhibiting the TGF-beta1/Smad pathway and altering the MMP2/TIMP2 ratio in rats. PLoS one, 6(11), e27710.
   PubMed Web of Science ®Google Scholar
• Yao, Q.Y., et al., 2012. Inhibition by curcumin of multiple sites of the transforming growth factor-beta1 signalling pathway ameliorates the progression of liver fibrosis induced by CCl4 in rats. BMC complementary and alternative medicine, 12(1), 156.
   PubMedGoogle Scholar
• Zhan, S.S., et al., 2006. Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo. Hepatology, 43(3), 435–443.
   PubMed Web of Science ®Google Scholar
• Zhang, J., et al., 2018. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice. Life sciences, 192, 46–54.
   PubMed Web of Science ®Google Scholar
• Zhang, Z., et al., 2017. Protective action of Se-supplement against acute alcoholism is regulated by selenoprotein P (SelP) in the liver. Biological trace element research, 175(2), 375–387.
   PubMed Web of Science ®Google Scholar
• Zhong, C., et al., 2015. Antihepatic fibrosis effect of active components isolated from green Asparagus (Asparagus officinalis L.) involves the inactivation of hepatic stellate cells. Journal of agricultural and food chemistry, 63(26), 6027–6034.
   PubMed Web of Science ®Google Scholar
• Zhou, L., et al., 2017. Casticin attenuates liver fibrosis and hepatic stellate cell activation by blocking TGF-β/Smad signaling pathway. Oncotarget, 8, 56267–56280.
   PubMedGoogle Scholar
• Zhou, Y., et al., 2009. Insulin secretion stimulating effects of mogroside V and fruit extract of luo han kuo (Siraitia grosvenori Swingle) fruit extract. Yao xue xue bao, 44(11), 1252–1257.
   PubMedGoogle Scholar